Orthofix Medical Inc

NASDAQ:OFIX   3:59:59 PM EDT
41.05
-1.50 (-3.52%)
Products

Orthofix Says FDA Recommends Pre-Market Clinical Evidence Requirement In Proposed Reclassification Of Bone Growth Stimulators

Published: 09/09/2020 12:11 GMT
Orthofix Medical Inc (OFIX) - FDA Advisory Panel Recommends Pre-market Clinical Evidence Requirement in Proposed Reclassification of Bone Growth Stimulators.
Orthofix Medical Inc - Will Be Submitting Comments in Response to FDA's Proposed Rulemaking to Underscore Advisory Panel's Recommendation.